These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4007876)

  • 1. Adverse drug reactions.
    Lawson DH
    Hum Toxicol; 1985 Mar; 4(2):122-6. PubMed ID: 4007876
    [No Abstract]   [Full Text] [Related]  

  • 2. Was it the drug?
    Lancet; 1982 Jul; 2(8292):251. PubMed ID: 6124679
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-marketing surveillance of adverse reactions to new medicines.
    Wilson AB
    Br Med J; 1977 Oct; 2(6093):1001-3. PubMed ID: 922357
    [No Abstract]   [Full Text] [Related]  

  • 4. Mass product-liability litigation.
    Gerber P
    Med J Aust; 1988 May; 148(10):485-8. PubMed ID: 3285149
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical drugs-the good and the not so good: together, we can make it better.
    Campbell AW
    Altern Ther Health Med; 2014; 20(1):9-11. PubMed ID: 24445351
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-marketing surveillance in the UK (1984).
    Lawson DH
    Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):71S-75S. PubMed ID: 3567035
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: The drug makers.
    Med J Aust; 1974 Oct; 2(16):583-4. PubMed ID: 4437418
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardized methods of causality assessment for suspected adverse drug reactions.
    Hutchinson TA; Lane DA
    J Chronic Dis; 1986; 39(11):857-60. PubMed ID: 3539961
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA tells drug and device makers to give balanced picture of risks in ads, labels.
    Kuehn BM
    JAMA; 2009 Jun; 301(24):2541. PubMed ID: 19549965
    [No Abstract]   [Full Text] [Related]  

  • 10. The law in relation to unforeseen adverse drug reactions.
    Wilmers J
    J R Coll Physicians Lond; 1977 Apr; 11(3):247-54. PubMed ID: 853464
    [No Abstract]   [Full Text] [Related]  

  • 11. Benoxaprofen case makes legal history.
    Dyer C
    Br Med J (Clin Res Ed); 1987 Jul; 295(6589):39-40. PubMed ID: 3113606
    [No Abstract]   [Full Text] [Related]  

  • 12. Communicating adverse drug reactions.
    Lancet; 1978 Jan; 1(8056):133. PubMed ID: 87560
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug discovery-background and foreground.
    Tishler M
    Clin Pharmacol Ther; 1973; 14(4):479-86. PubMed ID: 4723254
    [No Abstract]   [Full Text] [Related]  

  • 14. Settlement of the benoxaprofen case.
    Dyer C
    Br Med J (Clin Res Ed); 1988 Jan; 296(6615):109-10. PubMed ID: 3122945
    [No Abstract]   [Full Text] [Related]  

  • 15. Compensating the drug victim.
    Lancet; 1978 Jul; 2(8079):26. PubMed ID: 78220
    [No Abstract]   [Full Text] [Related]  

  • 16. Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
    Cahal DA
    Can Med Assoc J; 1968 Feb; 98(6):271-5. PubMed ID: 5636096
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring adverse reactions to drugs.
    Dollery CT; Rawlins MD
    Br Med J; 1977 Jan; 1(6053):96-7. PubMed ID: 832028
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effect reporting: pharmaceutical companies can't be trusted.
    Prescrire Int; 2015 Nov; 24(165):256. PubMed ID: 26688890
    [No Abstract]   [Full Text] [Related]  

  • 19. Are drug companies a little too vigorous?
    Radcliffe M
    Nurs Times; 2004 Jul 13-19; 100(28):156. PubMed ID: 15311541
    [No Abstract]   [Full Text] [Related]  

  • 20. "Opren scandal".
    Lancet; 1983 Jan; 1(8318):219-20. PubMed ID: 6130249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.